Purinergic P2X7 receptor antagonists: Chemistry and fundamentals of biological screening

2009 ◽  
Vol 17 (14) ◽  
pp. 4861-4865 ◽  
Author(s):  
Hendra Gunosewoyo ◽  
Mark J. Coster ◽  
Maxwell R. Bennett ◽  
Michael Kassiou
2021 ◽  
Vol 22 (11) ◽  
pp. 5978
Author(s):  
Hiroyuki Inoue ◽  
Hidetaka Kuroda ◽  
Wataru Ofusa ◽  
Sadao Oyama ◽  
Maki Kimura ◽  
...  

The ionotropic P2X receptor, P2X7, is believed to regulate and/or generate nociceptive pain, and pain in several neuropathological diseases. Although there is a known relationship between P2X7 receptor activity and pain sensing, its detailed functional properties in trigeminal ganglion (TG) neurons remains unclear. We examined the electrophysiological and pharmacological characteristics of the P2X7 receptor and its functional coupling with other P2X receptors and pannexin-1 (PANX1) channels in primary cultured rat TG neurons, using whole-cell patch-clamp recordings. Application of ATP and Bz-ATP induced long-lasting biphasic inward currents that were more sensitive to extracellular Bz-ATP than ATP, indicating that the current was carried by P2X7 receptors. While the biphasic current densities of the first and second components were increased by Bz-ATP in a concentration dependent manner; current duration was only affected in the second component. These currents were significantly inhibited by P2X7 receptor antagonists, while only the second component was inhibited by P2X1, 3, and 4 receptor antagonists, PANX1 channel inhibitors, and extracellular ATPase. Taken together, our data suggests that autocrine or paracrine signaling via the P2X7-PANX1-P2X receptor/channel complex may play important roles in several pain sensing pathways via long-lasting neuronal activity driven by extracellular high-concentration ATP following tissue damage in the orofacial area.


2015 ◽  
Vol 58 (21) ◽  
pp. 8413-8426 ◽  
Author(s):  
Francisco Lopez-Tapia ◽  
Keith A. M. Walker ◽  
Christine Brotherton-Pleiss ◽  
Joanie Caroon ◽  
Dov Nitzan ◽  
...  

2015 ◽  
Vol 3 (2) ◽  
pp. e00123 ◽  
Author(s):  
Swen Seeland ◽  
Hélène Kettiger ◽  
Mark Murphy ◽  
Alexander Treiber ◽  
Jasmin Giller ◽  
...  

2019 ◽  
Vol 14 (1) ◽  
pp. 32-38 ◽  
Author(s):  
Giorgia Scarpellino ◽  
Tullio Genova ◽  
Luca Munaron

Background: Purinergic signalling is involved in several physiological and pathophysiological processes. P2X7 Receptor (P2X7R) is a calcium-permeable ion channel that is gaining interest as a potential therapeutic target for the treatment of different diseases including inflammation, pain, psychiatric disorders and cancer. P2X7R is ubiquitously expressed and sensitive to high ATP levels, usually found in tumor microenvironment. P2X7R regulates several cell functions, from migration to cell death, but its selective contribution to tumor progression remains controversial.Objective:Current review was conducted to check involvement of P2X7R use in cancer treatment.Methods:We review the most recent patents focused on the use of P2X7R in the treatment of cancer.Results:P2X7R is an intriguing purinergic receptor that plays different roles in tumor progression.Conclusion:Powerful strategies able to selectively interfere with its expression and function should reveal helpful in the development of new anti-cancer therapies.


PLoS ONE ◽  
2013 ◽  
Vol 8 (12) ◽  
pp. e80707 ◽  
Author(s):  
Songyin Huang ◽  
Yongsong Chen ◽  
Wei Wu ◽  
Nengyong Ouyang ◽  
Jianing Chen ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document